MannKind Corp (MNKD)
4.20
+0.09
(+2.19%)
USD |
NASDAQ |
Apr 23, 14:18
MannKind Price: 4.20 for April 23, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 22, 2024 | 4.23 | 4.26 | 4.105 | 4.11 | 1.744M |
| Apr 19, 2024 | 4.06 | 4.20 | 4.02 | 4.18 | 1.798M |
| Apr 18, 2024 | 4.11 | 4.22 | 4.05 | 4.08 | 1.293M |
| Apr 17, 2024 | 4.09 | 4.145 | 3.97 | 4.10 | 2.453M |
| Apr 16, 2024 | 4.10 | 4.13 | 4.04 | 4.05 | 1.325M |
| Apr 15, 2024 | 4.16 | 4.21 | 4.10 | 4.12 | 1.601M |
| Apr 12, 2024 | 4.30 | 4.33 | 4.10 | 4.15 | 2.108M |
| Apr 11, 2024 | 4.29 | 4.38 | 4.20 | 4.30 | 1.494M |
| Apr 10, 2024 | 4.34 | 4.35 | 4.15 | 4.24 | 3.036M |
| Apr 09, 2024 | 4.47 | 4.60 | 4.385 | 4.44 | 2.064M |
| Apr 08, 2024 | 4.47 | 4.62 | 4.415 | 4.55 | 1.959M |
| Apr 05, 2024 | 4.30 | 4.54 | 4.21 | 4.44 | 2.573M |
| Apr 04, 2024 | 4.47 | 4.52 | 4.30 | 4.31 | 2.706M |
| Apr 03, 2024 | 4.30 | 4.49 | 4.22 | 4.43 | 2.813M |
| Apr 02, 2024 | 4.30 | 4.34 | 4.23 | 4.31 | 4.039M |
| Apr 01, 2024 | 4.52 | 4.52 | 4.30 | 4.34 | 2.721M |
| Mar 28, 2024 | 4.63 | 4.735 | 4.49 | 4.53 | 2.578M |
| Mar 27, 2024 | 4.90 | 4.93 | 4.52 | 4.63 | 5.867M |
| Mar 26, 2024 | 4.95 | 5.06 | 4.855 | 4.91 | 2.590M |
| Mar 25, 2024 | 4.92 | 5.11 | 4.89 | 4.90 | 1.912M |
| Mar 22, 2024 | 4.79 | 4.94 | 4.74 | 4.92 | 2.246M |
| Mar 21, 2024 | 4.87 | 4.96 | 4.70 | 4.76 | 2.512M |
| Mar 20, 2024 | 4.69 | 4.825 | 4.60 | 4.82 | 2.201M |
| Mar 19, 2024 | 4.61 | 4.70 | 4.54 | 4.67 | 1.824M |
| Mar 18, 2024 | 4.46 | 4.74 | 4.41 | 4.62 | 3.997M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
0.8415
Minimum
Mar 16 2020
6.135
Maximum
Feb 19 2021
3.272
Average
3.71
Median
Jun 02 2021
Price Benchmarks
| Cassava Sciences Inc | 20.69 |
| NovaBay Pharmaceuticals Inc | 0.0746 |
| Palatin Technologies Inc | 1.78 |
| iBio Inc | 1.93 |
| Theriva Biologics Inc | 0.375 |
Price Related Metrics
| PS Ratio | 5.927 |
| Earnings Yield | -0.95% |
| Market Cap | 1.136B |
| Operating PE Ratio | 111.31 |